Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangxin Ma

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Cell and Developmental Biology|October 31, 2022
The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemiaXiuhua Su, Guangxin Ma, Xiaoran Bai, et al.
Molecular Carcinogenesis|November 7, 2019
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophiliaGuangxin Ma, Deniz Gezer, Oliver Herrmann, et al.
Aging|August 5, 2023
An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancerYa-Wen Wang, Can Liu, Yan-Duo Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 8, 2026
Hierarchically Soft Porous MOF-Polymer Monolith for Fast and Large-Scale Moisture BufferingGuangxin Ma, Xin Zhou, Weiman Li, et al.
Molecules (Basel, Switzerland)|December 26, 2013
Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cellsYunshan Wang, Guangxin Ma, Qin Wang, et al.
Scientific Reports|June 5, 2024
Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphomaXiaoran Bai, Fei Lu, Shuying Li, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Cell and Developmental Biology|October 31, 2022
The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemiaXiuhua Su, Guangxin Ma, Xiaoran Bai, et al.
Molecular Carcinogenesis|November 7, 2019
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophiliaGuangxin Ma, Deniz Gezer, Oliver Herrmann, et al.
Aging|August 5, 2023
An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancerYa-Wen Wang, Can Liu, Yan-Duo Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 8, 2026
Hierarchically Soft Porous MOF-Polymer Monolith for Fast and Large-Scale Moisture BufferingGuangxin Ma, Xin Zhou, Weiman Li, et al.
Molecules (Basel, Switzerland)|December 26, 2013
Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cellsYunshan Wang, Guangxin Ma, Qin Wang, et al.
Scientific Reports|June 5, 2024
Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphomaXiaoran Bai, Fei Lu, Shuying Li, et al.
Pageof 2